Pluristem Therapeutics Inc.


FBR Capital Analyst Bullish on Pluristem Therapeutics Inc. (PTSI) Following Pipeline Study Announcement

FBR Capital analyst Vernon Bernardino weighed in on Pluristem Therapeutics Inc. (NASDAQ:PSTI) following the an announcement that the company plans to initiate a Phase I trial to …

Maxim Weighs In on Anavex Life Sciences Corp. (AVXL), Pluristem Therapeutics Inc. (PSTI) Following Orphan Designation and Preclinical Data

Maxim’s healthcare analyst Jason Kolbert weighed in today on two names in his coverage universe, Anavex Life Sciences Corp. (NASDAQ:AVXL) and Pluristem Therapeutics Inc.

Wednesday’s Market Insights: Tesla Motors Inc (TSLA), SolarCity Corp (SCTY), Pluristem Therapeutics Inc. (PSTI), Adobe Systems Incorporated (ADBE)

Tesla Motors Inc (NASDAQ:TSLA) is falling over 11% in pre-market trading following news that the electric car marker will purchase SolarCity Corp (NASDAQ:SCTY) …

H.C. Wainwright Reiterates Buy on Pluristem Therapeutics Inc. Following FY4Q15 Financial Results

In a research report issued today, H.C.

Maxim Remains Positive on Pluristem Therapeutics Inc. Ahead of PLX-R18 Initiation

In a research report released Wednesday, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of Pluristem Therapeutics Inc. (NASDAQ:PSTI) with an $8 price …

Maxim Group Maintains Buy on Pluristem Therapeutics Inc. Following Patent Issuance

In a research report released Monday, Maxim Group analyst Jason Kolbert maintained a Buy rating on shares of Pluristem Therapeutics Inc. (NASDAQ:PSTI) with an …

MLV Offers Commentary on Pluristem Therapeutics Inc. Following Regulatory Updates

In a research report released today, MLV’s healthcare analyst Vernon Bernardino reiterated a Buy rating on shares of Pluristem Therapeutics Inc (NASDAQ:PSTI), with a $6 …

Monday Morning’s Pre-Market Insights: Youku Tudou Inc (ADR) (YOKU), QUALCOMM, Inc. (QCOM), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Pluristem Therapeutics Inc. (PSTI)

Youku Tudou Inc (ADR) (NYSE:YOKU) shares slipped more than -6% in pre-market trading down to $18.77 after Chinese shares fell more than 8%.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts